Manila Bulletin
Senior citizens, immunocompromised individuals may choose COVID-19 vax brand for 3rd dose---DOH
Senior citizens (A2) and immunocompromised individuals (A3) can choose their preferred vaccine brands for their additional doses, according to the Department of Health (DOH).
The DOH is set to release guidelines soon for the rollout of these additional doses after consulting with health experts.
For immunocompromised individuals, the additional dose will be considered a third dose due to medical indications.
Both homologous (same brand) and heterologous (different brand) vaccination options will be available for these priority groups.
The guidelines will provide the public with information regarding these choices.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines officially commenced the administration of COVID-19 booster shots to senior citizens on Monday, November 22.
+2
Read more →
Frontline healthcare workers in the Philippines can now select their preferred COVID-19 vaccine brand for their booster shots, whether it matches their primary series or is a different brand.
+1
Read more →
The Department of Health announced that over 100,000 booster and additional vaccine doses have been administered in the Philippines.
Read more →
An expert from the Department of Science and Technology Vaccine Expert Panel (DOST-VEP), Dr. Nina Gloriani, recommended that senior citizens, immunocompromised individuals, and those who are fully vaccinated should receive their COVID-19 booster shots three to five months after their second dose.
Read more →
The Food and Drug Administration (FDA) has authorized four COVID-19 vaccine brands – Pfizer-BioNTech, AstraZeneca, and Sinovac – to be used as homologous (same brand) additional doses.
Read more →